Israel Englander Abbott Laboratories Put Options Transaction History

Millennium Management LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $27.3 Million - $30.4 Million	-270,600 Reduced 29.23%	655,100 $68.1 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $14.5 Million - $16 Million	132,100 Added 16.65%	925,700 $105 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $27.1 Million - $33.2 Million	300,400 Added 60.91%	793,600 $87.4 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $28.8 Million - $32.1 Million	-286,200 Reduced 36.72%	493,200 $53.8 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $55.7 Million - $65.6 Million	-575,100 Reduced 42.46%	779,400 $78.9 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $9.93 Million - $11.7 Million	-104,500 Reduced 7.16%	1,354,500 $149 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $112 Million - $130 Million	1,156,700 Added 382.63%	1,459,000 $141 Million

3,177

1.33B

8.62M

7.18M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.